This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code describes only one unique lab test made by a specific manufacturer or performed by a specific lab. Code 0023U describes LeukoStrat® CDx FLT3 Mutation Assay by Invivoscribe Technologies, Inc., which is a molecular pathology test to identify mutations in the FLT3 gene to aid in treatment planning for patients with acute myelogenous leukemia (AML).
For clinical responsibility, terminology, tips and additional info
start codify free trial.